Provectus Biopharmaceuticals (PVCT) Stock Chart & Stock Price History → Urgent Nvidia Warning (From Altimetry) (Ad) Free PVCT Stock Alerts $0.19 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Provectus Biopharmaceuticals Stock Price Performance5 Day Performance-2.99%1 Month Performance+25.97%3 Month Performance+50.59%6 Month Performance+77.11%Year-To-Date Performance+101.09%1 Year Performance+41.81% Receive PVCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit PVCT Stock Chart for Saturday, May, 4, 2024 PVCT Chart by TradingView Provectus Biopharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$0.19$0.19+0.94%$0.20$0.19128,865 shs$81.01 million05/02/2024$0.19$0.19-1.85%$0.20$0.19106,247 shs$80.25 million05/01/2024$0.20$0.19-2.06%$0.20$0.1981,575 shs$81.76 million04/30/2024$0.20$0.20$0.20$0.19149,227 shs$83.48 million04/29/2024$0.20$0.20+0.25%$0.20$0.19147,637 shs$83.48 million04/26/2024$0.20$0.20+1.07%$0.20$0.1939,676 shs$83.27 million Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$0.19$0.20+1.24%$0.20$0.19251,000 shs$82.39 million04/24/2024$0.19$0.19-0.41%$0.19$0.1867,734 shs$81.38 million04/23/2024$0.19$0.19$0.19$0.19117,785 shs$81.72 million04/22/2024$0.19$0.19$0.19$0.1963,395 shs$81.72 million04/19/2024$0.20$0.19-0.10%$0.19$0.18198,647 shs$81.72 million04/18/2024$0.19$0.20+2.63%$0.20$0.1956,279 shs$81.80 million04/17/2024$0.18$0.19+5.61%$0.19$0.1460,302 shs$79.71 million04/16/2024$0.17$0.18+7.40%$0.18$0.16665,710 shs$75.47 million04/15/2024$0.17$0.17+0.06%$0.17$0.1642,451 shs$70.27 million04/12/2024$0.18$0.17-7.97%$0.18$0.1725,580 shs$70.22 million04/11/2024$0.17$0.18+7.19%$0.18$0.1633,474 shs$76.31 million04/10/2024$0.16$0.17+6.06%$0.17$0.16152,672 shs$71.19 million04/09/2024$0.14$0.16+10.67%$0.16$0.1484,423 shs$67.12 million04/08/2024$0.15$0.14-2.97%$0.15$0.14420,940 shs$60.65 million04/05/2024$0.15$0.15-2.77%$0.15$0.14445,472 shs$62.51 million04/04/2024$0.16$0.15-4.16%$0.16$0.15183,315 shs$64.29 million04/03/2024$0.17$0.16-8.42%$0.17$0.15333,259 shs$67.08 million04/02/2024$0.19$0.17-8.15%$0.18$0.17174,062 shs$73.25 million04/01/2024$0.18$0.19+3.96%$0.20$0.17532,511 shs$79.75 million03/29/2024$0.18$0.18-0.03%$0.20$0.18236,436 shs$76.71 million03/28/2024$0.20$0.18-8.55%$0.20$0.18236,436 shs$76.73 million03/27/2024$0.20$0.20+1.52%$0.21$0.19470,642 shs$83.90 million03/26/2024$0.20$0.20-1.50%$0.20$0.19464,715 shs$82.64 million03/25/2024$0.19$0.20+4.93%$0.20$0.18262,975 shs$83.90 million03/22/2024$0.20$0.19-3.74%$0.20$0.18213,258 shs$79.96 million03/21/2024$0.20$0.20-0.95%$0.20$0.18141,361 shs$83.06 million03/20/2024$0.20$0.20+1.22%$0.20$0.2080,350 shs$83.86 million03/19/2024$0.20$0.20-1.25%$0.20$0.18344,431 shs$82.85 million03/18/2024$0.22$0.20-7.79%$0.22$0.20664,452 shs$83.90 million03/15/2024$0.20$0.22+8.45%$0.22$0.20151,268 shs$90.99 million03/14/2024$0.21$0.20-3.29%$0.21$0.2073,977 shs$83.90 million03/13/2024$0.21$0.21-3.18%$0.22$0.19338,696 shs$86.75 million03/12/2024$0.20$0.21+4.96%$0.22$0.21484,508 shs$89.61 million03/11/2024$0.20$0.20+2.39%$0.22$0.20416,603 shs$85.37 millionConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.03/08/2024$0.21$0.20-6.75%$0.22$0.181.91 million shs$83.40 million03/07/2024$0.17$0.21+25.41%$0.22$0.171.88 million shs$89.44 million03/06/2024$0.17$0.17+0.95%$0.17$0.151.02 million shs$71.32 million03/05/2024$0.17$0.17-0.18%$0.17$0.1689,055 shs$70.64 million03/04/2024$0.16$0.17+6.77%$0.17$0.151.41 million shs$70.77 million03/01/2024$0.15$0.16+6.25%$0.16$0.15501,235 shs$66.28 million02/29/2024$0.15$0.15+1.78%$0.15$0.14208,279 shs$62.38 million02/28/2024$0.15$0.15+0.76%$0.15$0.1486,225 shs$61.29 million02/27/2024$0.14$0.15+0.90%$0.15$0.14203,938 shs$60.83 million02/26/2024$0.14$0.14+1.13%$0.14$0.14159,080 shs$60.28 million02/23/2024$0.14$0.14-1.93%$0.14$0.14186,278 shs$59.61 million02/22/2024$0.14$0.14+2.04%$0.14$0.14648,829 shs$60.79 million02/21/2024$0.14$0.14+0.28%$0.14$0.14239,913 shs$59.57 million02/20/2024$0.14$0.14+1.87%$0.14$0.14220,219 shs$59.40 million02/19/2024$0.14$0.14+0.04%$0.14$0.1486,800 shs$58.31 million02/16/2024$0.14$0.14+2.36%$0.14$0.1486,840 shs$58.31 million02/15/2024$0.14$0.14-0.44%$0.14$0.13101,231 shs$56.97 million02/14/2024$0.13$0.14+2.17%$0.14$0.1384,170 shs$57.22 million02/13/2024$0.13$0.13+3.73%$0.14$0.1399,324 shs$56.00 million02/12/2024$0.14$0.13-5.85%$0.14$0.12138,459 shs$53.99 million02/09/2024$0.13$0.14+5.15%$0.14$0.12476,038 shs$57.35 million02/08/2024$0.13$0.13+0.23%$0.15$0.12926,729 shs$54.54 million02/07/2024$0.13$0.13$0.13$0.1296,814 shs$54.41 million02/06/2024$0.13$0.13+2.21%$0.13$0.12130,702 shs$54.41 million02/05/2024$0.13$0.13-1.01%$0.13$0.12239,370 shs$53.24 million Related Companies: LPTX Stock Price Chart AFMD Stock Price Chart LFVN Stock Price Chart CMRX Stock Price Chart ALRN Stock Price Chart QTTB Stock Price Chart IFRX Stock Price Chart ATBPD Stock Price Chart ONCY Stock Price Chart ETON Stock Price Chart Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PVCT) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.